Startups

Greenairy develops smart plant towers to reduce toxic gases in office air

The startup Greenairy is testing plant towers designed to draw in indoor air and break down volatile organic compounds, saying its initial trials in Singapore recorded a 50% reduction in average levels of these compounds and their daily peaks. It plans to publish results verified by TÜV SÜD and begin commercial production in 2027.

2026-10-07
4 min read
250 views
certi.news Editorial Team
Greenairy develops smart plant towers to reduce toxic gases in office air

The startup Greenairy is developing plant towers designed for indoor spaces, with the aim of addressing toxic gases in the air of offices, schools, hotels and commercial buildings, rather than merely capturing dust and fine particles. The company says initial trials conducted at sites in Singapore showed a 50% reduction in average levels of volatile organic compounds and their daily peaks during working hours.

The company’s idea began after its founders, Tanvi Thombre and Lakshya Saraf, were exposed while working in a university laboratory to fumes from laser cutters, 3D printers and soldering irons. According to Thombre’s account, they did not notice the problem until her close friend fainted and was taken to hospital. This led the founders to study indoor air pollution, particularly in buildings that rely on air conditioning and keep their windows closed.

From particle purification to targeting gases

Greenairy is based on the observation that conventional air purifiers may be effective at removing dust and pollen, but do not address gases such as carbon dioxide, formaldehyde and benzene to the same extent, many of which fall under the category of volatile organic compounds. According to information provided by the company, these substances are associated with chronic health risks and with what is known as sick building syndrome, in which building occupants experience health symptoms or discomfort without a specific disease being identified.

Greenairy’s towers collect air and direct it through a plant-based environment designed to accelerate the breakdown of gases, then release the purified air. The company says that modifying the conditions surrounding the plants makes them faster-acting than a plant grown in an ordinary pot. It also presents the plants as an alternative that does not require filters to be replaced periodically and that, according to its description, does not produce harmful byproducts.

Initial results require independent publication

In its tests, the company compared three offices: one equipped with Greenairy towers, a second with a medical ionizer and a third with an air purifier equipped with a HEPA filter. It used RESET-certified air-monitoring devices, and Saraf says the company’s towers recorded the lowest levels of volatile organic compounds and the fastest removal rate. Thombre also reported an immediate improvement during working hours, with further improvement as the plants and microbes matured.

However, these results have so far been presented by the company itself, and their full details have not yet been published. Greenairy says that the German testing and certification company TÜV SÜD verified the results and that it will publish them later, while they are currently available upon request. It is therefore not possible, based on the available material, to assess the sample size, the duration of the trials or whether the results can be replicated in different buildings and environments.

What changes in practice?

If the published results are confirmed, plant towers could offer a complementary option to air purifiers in places where gases and volatile organic compounds represent a problem independent of particles. However, practical reliance on them will remain linked to detailed testing data, maintenance requirements and the system’s long-term performance, as well as manufacturing and installation costs.

Saraf is currently in Berkeley, California, while Thombre is based in Singapore; the former is focusing on fundraising and the latter on testing. The company expects the founders to move to Singapore during the first half of 2027, when it plans to launch its first mass-produced towers and install them at its initial customers’ sites in Singapore.

News source
TechCrunch Startups
Open original source ↗
c
Author

certi.news Editorial Team

What you need to know

Greenairy is developing smart plant towers to treat volatile organic compounds and toxic gases in office air, and says initial trials in Singapore showed a 50% reduction. The results have not yet been fully published, and the company plans to begin commercial production and install the first towers at customer sites in Singapore during 2027.

  • Greenairy’s towers draw air through a plant-based environment designed to accelerate the breakdown of gases, then release purified air.
  • The towers target gases such as formaldehyde, benzene, and carbon dioxide, in addition to volatile organic compounds.
  • The company compared its towers with a medical ionizer and an air purifier equipped with a HEPA filter in three offices.
  • Greenairy says its trials in Singapore recorded a 50% reduction in average volatile organic compound levels and their daily peaks.
  • The trial details have not been published in full, so the sample size, testing duration, and replicability of the results cannot be assessed.
  • The company plans to launch its first mass-produced towers and install them at its early customers’ sites in Singapore during 2027.

FAQ

What gases do Greenairy’s towers target?

The towers target volatile organic compounds and gases such as formaldehyde, benzene, and carbon dioxide.

What preliminary results has the company announced?

Greenairy says trials at sites in Singapore showed a 50% reduction in average volatile organic compound levels and their daily peaks during working hours.

When does Greenairy plan to begin commercial production?

The company plans to launch its first mass-produced towers and install them at early customers’ sites in Singapore during 2027.

Have the results been independently confirmed?

The company says TÜV SÜD verified the results, but the full details have not yet been published, so the article does not allow the sample size, trial duration, or replicability to be assessed.

In the same category

You may also like

View all news